Halozyme Therapeutics, Inc. (LON:0J2O)
London · Delayed Price · Currency is GBP · Price in USD 57.10
-0.77 (-1.32%)
At close: Jul 18, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Revenue Under Collaborative Agreements | 140.84M | Log In | Log In | Log In | Log In | Upgrade |
Revenue Under Collaborative Agreements Growth | 49.45% | Log In | Log In | Log In | Log In | Upgrade |
Royalties | 570.99M | Log In | Log In | Log In | Log In | Upgrade |
Royalties Growth | 31.95% | Log In | Log In | Log In | Log In | Upgrade |
Sales of Proprietary Products | 166.62M | Log In | Log In | Log In | Log In | Upgrade |
Sales of Proprietary Products Growth | 21.42% | Log In | Log In | Log In | Log In | Upgrade |
Sales of Bulk rHuPH20 | 86.33M | Log In | Log In | Log In | Log In | Upgrade |
Sales of Bulk rHuPH20 Growth | -1.00% | Log In | Log In | Log In | Log In | Upgrade |
Sales of Device Partnered Products | 50.54M | Log In | Log In | Log In | Log In | Upgrade |
Sales of Device Partnered Products Growth | -7.48% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Other | 9.53M | Log In | Log In | Log In | Log In | Upgrade |
United States | 690.46M | Log In | Log In | Log In | Log In | Upgrade |
United States Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Switzerland | 212.39M | Log In | Log In | Log In | Log In | Upgrade |
Switzerland Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Japan | 18.94M | Log In | Log In | Log In | Log In | Upgrade |
Japan Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Ireland | - | Log In | Log In | Log In | Log In | Upgrade |
Ireland Growth | - | Log In | Log In | Log In | Log In | Upgrade |
All Other Foreign Countries Revenue (Pre-FY2023) | - | Log In | Log In | Log In | Log In | Upgrade |
All Other Foreign Countries Revenue (Pre-FY2023) Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Belgium | 84.01M | Log In | Log In | Log In | Log In | Upgrade |
Belgium Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | 9.53M | Log In | Log In | Log In | Log In | Upgrade |